Brief: Herantis Pharma H2 Loss For Period Narrows To EUR 3.7 Mln

Herantis Pharma Oyj

02/03/2023 06:18

March 2 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * H2 LOSS FOR PERIOD EUR 3.7 MILLION VERSUS LOSS EUR 4.9
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr5SlkHz 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))